Downregulation of indoleamine 2, 3-dioxygenase expression in the villous stromal endothelial cells of placentas with preeclampsia
- PMID: 28131097
- DOI: 10.1016/j.jri.2017.01.003
Downregulation of indoleamine 2, 3-dioxygenase expression in the villous stromal endothelial cells of placentas with preeclampsia
Abstract
Introduction: Previous studies have shown that indoleamine 2, 3-dioxygenase (IDO), an immunosuppressive enzyme that converts tryptophan to kynurenine, is expressed in the placenta and might play a role in the maintenance of pregnancy, although its associations with the pathogeneses of preeclampsia (PE) and fetal growth restriction (FGR) remain unclear. The objective of this study was to investigate the differences in IDO expression among normal, PE, and FGR placentas, and the associations between IDO expression and clinical symptoms, or the expression of fms-like tyrosine kinase receptor-1 (Flt-1).
Methods: Immunohistochemical studies of IDO and Flt-1 expression were performed in human placentas that were complicated with FGR alone (n=19), PE alone (n=20), or both PE and FGR (n=39), and gestational age-matched controls (n=23).
Results: It was found that IDO was expressed on endothelial cells in the villous stroma, while Flt-1 was located on trophoblast cells. The IDO expression level of the PE alone group was significantly lower than those of the FGR alone and control groups. The IDO expression of the PE+FGR group was significantly lower than that of the FGR alone group. Lower IDO expression was significantly correlated with more severe maternal hypertension or proteinuria in PE patients, who exhibited higher Flt-1 expression. The late onset PE patients exhibited significantly lower IDO expression than the early onset PE patients.
Conclusion: This study demonstrated that the downregulation of IDO expression on the endothelial cells of the villous stroma was associated with PE, but not FGR, suggesting that IDO might be involved in the pathophysiology of PE.
Keywords: 3-Dioxygenase; Fetal growth restriction; Indoleamine 2; Placenta; Preeclampsia.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
The expression of connective tissue growth factor in pregnancies complicated by severe preeclampsia or fetal growth restriction.Placenta. 2009 Nov;30(11):981-7. doi: 10.1016/j.placenta.2009.08.006. Epub 2009 Sep 16. Placenta. 2009. PMID: 19762080
-
Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction.Placenta. 2017 Mar;51:1-9. doi: 10.1016/j.placenta.2017.01.002. Epub 2017 Jan 4. Placenta. 2017. PMID: 28292463
-
Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction.FASEB J. 2001 May;15(7):1158-68. doi: 10.1096/fj.00-0376com. FASEB J. 2001. PMID: 11344084
-
The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies.Am J Reprod Immunol. 2018 Apr;79(4):e12786. doi: 10.1111/aji.12786. Epub 2017 Nov 20. Am J Reprod Immunol. 2018. PMID: 29154462 Review.
-
Indoleamine 2,3-dioxygenase in materno-fetal interaction.Curr Drug Metab. 2007 Apr;8(3):205-8. doi: 10.2174/138920007780362491. Curr Drug Metab. 2007. PMID: 17430108 Review.
Cited by
-
Examining the Aryl Hydrocarbon Receptor Network in the Placental Tissues of Pregnancies Complicated by Pre-Eclampsia: An Explorative Case-Control Analysis.Life (Basel). 2023 Oct 26;13(11):2122. doi: 10.3390/life13112122. Life (Basel). 2023. PMID: 38004262 Free PMC article.
-
The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression.Curr Hypertens Rep. 2023 Jun;25(6):77-89. doi: 10.1007/s11906-023-01233-9. Epub 2023 Apr 12. Curr Hypertens Rep. 2023. PMID: 37043097 Free PMC article. Review.
-
Human Chorionic Gonadotropin-Stimulated Interleukin-4-Induced-1 (IL4I1) Promotes Human Decidualization via Aryl Hydrocarbon Receptor.Int J Mol Sci. 2023 Feb 5;24(4):3163. doi: 10.3390/ijms24043163. Int J Mol Sci. 2023. PMID: 36834576 Free PMC article.
-
The Role of the Kynurenine Pathway in the (Patho) physiology of Maternal Pregnancy and Fetal Outcomes: A Systematic Review.Int J Tryptophan Res. 2022 Nov 30;15:11786469221135545. doi: 10.1177/11786469221135545. eCollection 2022. Int J Tryptophan Res. 2022. PMID: 36467775 Free PMC article. Review.
-
The Footprint of Kynurenine Pathway in Cardiovascular Diseases.Int J Tryptophan Res. 2022 Jun 28;15:11786469221096643. doi: 10.1177/11786469221096643. eCollection 2022. Int J Tryptophan Res. 2022. PMID: 35784899 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous